PT - JOURNAL ARTICLE AU - Marek Kochańczyk AU - Frederic Grabowski AU - Tomasz Lipniacki TI - Accounting for super-spreading gives the basic reproduction number <em>R</em><sub>0</sub> of COVID-19 that is higher than initially estimated AID - 10.1101/2020.04.26.20080788 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.26.20080788 4099 - http://medrxiv.org/content/early/2020/05/01/2020.04.26.20080788.short 4100 - http://medrxiv.org/content/early/2020/05/01/2020.04.26.20080788.full AB - Transmission of infectious diseases is characterized by the basic reproduction number R0, a metric used to assess the threat posed by an outbreak and inform proportionate preventive decision-making. Based on individual case reports from the initial stage of the coronavirus disease 2019 epidemic, R0 is often estimated to range between 2 and 4. In this report, we show that a SEIR model that properly accounts for the distribution of the incubation period suggests that R0 lie in the range 4.4–11.7. This estimate is based on the doubling time observed in the near-exponential phases of the epidemic spread in China, United States, and six European countries. To support our empirical estimation, we analyze stochastic trajectories of the SEIR model showing that in the presence of super-spreaders the calculations based on individual cases reported during the initial phase of the outbreak systematically overestimate the doubling time and thus underestimate the actual value of R0.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the National Science Centre (Poland) grant 2018/29/B/NZ2/00668.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are provided in manuscript and references therein